FDA NDC Directory · JSON-LD · Markdown

loratadine D

NDC 45802-122 · HUMAN OTC DRUG · TABLET, FILM COATED, EXTENDED RELEASE

Generic nameloratadine, Pseudoephedrine sulfate
Labeler / ManufacturerPadagis Israel Pharmaceuticals Ltd
Marketing categoryAbbreviated NDA (generic) · App ANDA076050
Dosage form / routeTABLET, FILM COATED, EXTENDED RELEASE · ORAL
Active ingredientsLORATADINE (5 mg/1)
PSEUDOEPHEDRINE SULFATE (120 mg/1)
Marketing started20180410
Package count3

External sources

Source: openFDA. Public-domain (CC0).